SONN - Sonnet BioTherapeutics Holdings, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.3 -0.16 (-3.72%)	---	---	---	0.05 (1.16%)	-0.46 (-10.41%)	0.12 (2.99%)	0.12 (2.99%)

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.89
Diluted EPS:: -0.89
Basic P/E:: -4.6517
Diluted P/E:: -4.6517
RSI(14) 1m:: 100.0
VWAP:: 4.14
RVol:: 0.3996

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.98 +0.04 (+1.02%)	Oct 15 14:42
1m	Price increase 1m	3.98 +0.04 (+1.14%)	Oct 15 13:40
1m	Price decrease 1m	3.88 -0.1 (-2.51%)	Oct 15 13:12
1m	Price decrease 1m	4.02 -0.06 (-1.47%)	Oct 15 12:39
1m	Price increase 1m	4.13 +0.05 (+1.23%)	Oct 15 12:29